Axogen Projects 20 Percent Revenue Jump in Preliminary 2025 Figures

Tampa, Monday, 12 January 2026.
Preliminary data reveals Axogen’s 2025 revenue surged over 20% to $225.2 million, validating its growth strategy following the recent FDA approval of its Avance nerve repair solution.